"I'm wildly bullish, and I may be dead wrong, but I'm wildly bullish."
Farmer Brothers, a prominent coffee manufacturer and distributor, recently announced its financial results for the third quarter, which fell short of expectations. The company's GAAP EPS came in at -$0.57, missing expectations by $0.17, and its revenue of $124.2 million also fell short by $9.8 …
Conns, the home goods retailer operating through credit and retail segments, has experienced a significant downturn in its financial performance during the third quarter of FY23. With a decline in sales across all departments, the company reported a 20.7% decrease in revenues, amounting to $321.2 …
As an investor, I've come across an intriguing statistic that has piqued my curiosity. CytoDyn, a biotech company specializing in innovative therapies, is currently facing a federal indictment. With their former CEO under scrutiny for issuing false statements and misleading documents, the company has found …
The recent initial public offering (IPO) of Monogram Orthopedics has resulted in a significant surge in the company's stock prices. Monogram Orthopedics' shares experienced a remarkable increase of up to 317%, with the stock opening at $38 and reaching an early high of $48.99. Despite …
Carvana, the online used car marketplace, is facing a significant decline in its stock price amid concerns over its debt restructuring plan. The company's credit rating has been downgraded by S&P Global Ratings, and the proposed debt exchange could potentially be classified as a default …
In the highly competitive arena of large-cap exchange-traded funds (ETFs), two formidable contenders have emerged: SCHX and VOO. Boasting total assets of over $29B and $264B respectively, these funds have established their credibility and size in the market. With SCHX tracking the Dow Jones US …
Geron's Imetelstat has emerged as a potential game-changer in the field of hematological cancers. Despite facing competition from other pharmaceutical companies and safety concerns regarding discontinuation rates, this telomerase inhibitor aims to halt the proliferation of malignant hematopoietic stem cells. Geron is the only company …
In a surprising turn of events, Walmart's CEO has made a massive stock sale that has sent shockwaves through the market. This significant stock sale has raised questions and speculation about its potential impact on the company's stock performance and overall market perception. As one …
Stryker Corporation, a prominent player in the medical technologies industry, has garnered widespread attention due to its substantial market capitalization of over $100 billion. With its strong presence in the market, Stryker's revenue streams are primarily derived from its MedSurg & Neurotechnology division, accounting for …
Wow, hold on to your seat because I'm about to take you on an incredible journey of explosive growth with the billion-dollar luxury giant, Kering. This company's rise to the top has been nothing short of phenomenal, and as a luxury industry enthusiast, I can't …